{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:14:55Z","timestamp":1774422895518,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000071","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN267200700051C"],"award-info":[{"award-number":["HHSN267200700051C"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201000003I"],"award-info":[{"award-number":["HHSN275201000003I"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of Orphan Product Development","award":["R01 FD005101"],"award-info":[{"award-number":["R01 FD005101"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R34 HL124038"],"award-info":[{"award-number":["R34 HL124038"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Advancing Translational Sciences","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH-1R21HD080606-01A1"],"award-info":[{"award-number":["NIH-1R21HD080606-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jpeds.2018.11.041","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T02:27:17Z","timestamp":1545359237000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Surfactant Administration in Preterm Infants: Drug Development Opportunities"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-7976","authenticated-orcid":false,"given":"Genevieve","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9403-381X","authenticated-orcid":false,"given":"Wesley","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec","family":"Koss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreekar","family":"Mantena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Homsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blair","family":"Gattis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menefese","family":"Kudumu-Clavell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7363-4640","authenticated-orcid":false,"given":"Reese","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Laughon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.11.041_bib0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.2009-2959","article-title":"Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network","volume":"126","author":"Stoll","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpeds.2015.11.017","article-title":"Neonatal infection and later neurodevelopmental risk in the very preterm infant","volume":"170","author":"Rand","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0025","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(17)30312-4","article-title":"The evolution of modern respiratory care for preterm infants","volume":"389","author":"Owen","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1542\/peds.2013-3443","article-title":"Surfactant replacement therapy for preterm and term neonates with respiratory distress","volume":"133","author":"Polin","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00003246-199006000-00002","article-title":"Effect of single dose surfactant on pulmonary function","volume":"18","author":"Bhat","year":"1990","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(05)81660-9","article-title":"Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease","volume":"116","author":"Couser","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.79.1.31","article-title":"Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease","volume":"79","author":"Gitlin","year":"1987","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jpeds.2018.11.041_bib0050","article-title":"Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants","author":"Soll","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1016\/j.jpeds.2018.11.041_bib0055","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/sj.jp.7211320","article-title":"Overview of surfactant replacement trials","volume":"25","author":"Suresh","year":"2005","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.04.053","article-title":"Comparative effectiveness of surfactant preparations in premature infants","volume":"163","author":"Trembath","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.jp.7211242","article-title":"The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more","volume":"25","author":"Clark","year":"2005","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0070","series-title":"Curosurf [package label]","author":"Chiesi Farmaceutici","year":"2014"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0075","series-title":"Survanta [package label]","author":"AbbVie, Inc","year":"2013"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0080","series-title":"Infasurf [package label]","author":"ONY, Inc","year":"2011"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3109\/14767050903572174","article-title":"The INSURE method in preterm infants of less than 30 weeks' gestation","volume":"23","author":"Dani","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12098-014-1585-2","article-title":"The Pediatrix BabySteps Data Warehouse\u2014a unique national resource for improving outcomes for neonates","volume":"82","author":"Spitzer","year":"2015","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0095","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1542\/peds.2009-0913","article-title":"New intrauterine growth curves based on United States data","volume":"125","author":"Olsen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/INF.0000000000000115","article-title":"Predictors of positive cerebrospinal fluid cultures in infants with bacteremia","volume":"33","author":"Beam","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0105","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/14767058.2017.1313828","article-title":"Effects of surfactant treatment in late preterm infants with respiratory distress syndrome","volume":"31","author":"Dani","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0110","first-page":"239","article-title":"Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond","volume":"54","author":"S\u00fcrmeli-Onay","year":"2012","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/jp.2016.272","article-title":"Surfactant reduced the mortality of neonates with birth weight \u22651500\u2009g and hypoxemic respiratory failure: a survey from an emerging NICU network","volume":"37","author":"Wang","year":"2017","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.jpeds.2018.11.041_bib0120","article-title":"Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome","author":"Stevens","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.jp.7211381","article-title":"Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial","volume":"25","author":"Reininger","year":"2005","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0130","first-page":"804","article-title":"Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial","volume":"144","author":"Escobedo","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0135","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199410203311603","article-title":"Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group","volume":"331","author":"Verder","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.2016.10708","article-title":"Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis","volume":"316","author":"Isayama","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1542\/peds.2013-3442","article-title":"Respiratory support in preterm infants at birth","volume":"133","author":"Committee on Fetus and Newborn; American Academy of Pediatrics","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0155","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM195912242612604","article-title":"Fatal circulatory collapse in premature infants receiving chloramphenicol","volume":"261","author":"Burns","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0160","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.101.5.e7","article-title":"Early dexamethasone therapy in preterm infants: a follow-up study","volume":"101","author":"Yeh","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children","volume":"133","author":"Frattarelli","year":"2014","journal-title":"Pediatrics"},{"issue":"3 Pt 2","key":"10.1016\/j.jpeds.2018.11.041_bib0170","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1542\/peds.2005-0620B","article-title":"The newborn drug development initiative","volume":"117","author":"Giacoia","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2016.18131","article-title":"The Pediatric Research Equity Act moves into adolescence","volume":"317","author":"Bourgeois","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamapediatrics.2013.4208","article-title":"Drug labeling and exposure in neonates","volume":"168","author":"Laughon","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0190","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mayocp.2012.04.017","article-title":"Ten common questions (and their answers) about off-label drug use","volume":"87","author":"Wittich","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0195","doi-asserted-by":"crossref","first-page":"e1242","DOI":"10.1542\/peds.2010-3487","article-title":"Extrapolation of adult data and other data in pediatric drug-development programs","volume":"128","author":"Dunne","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0200","author":"Department of Health and Human Services"},{"issue":"12","key":"10.1016\/j.jpeds.2018.11.041_bib0205","article-title":"Surfactant for meconium aspiration syndrome in term and late preterm infants","author":"El Shahed","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2018.11.041_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0035-1556883","article-title":"The role of surfactant therapy in nonrespiratory distress syndrome conditions in neonates","volume":"33","author":"Keiser","year":"2016","journal-title":"Am J Perinatol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618316883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347618316883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:02:00Z","timestamp":1758358920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347618316883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":41,"alternative-id":["S0022347618316883"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.11.041","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surfactant Administration in Preterm Infants: Drug Development Opportunities","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.01.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.11.043","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}